Pharmaledger
PharmaLedger Association is a Swiss non-profit building a blockchain-based Digital Trust Ecosystem in Healthcare. It serves pharmaceutical manufacturers, providers, patients, and regulators with electronic product information, supply chain traceability, and a GxP-qualified open-source blockchain platform.
- Company typePrivate
- Founded2022
- HeadquartersManchester, United Kingdom
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Pharmaledger does
PharmaLedger Association (PLA) is a Swiss non-profit membership association, registered in Basel under Swiss Civil Code (CHE-178.875.143) and operating a Digital Trust Ecosystem in Healthcare (DTE-H). Founded in March 2022 as the post-project sustainability vehicle for the EU-funded PharmaLedger Project (2020-2022, Innovative Medicines Initiative), PLA builds and operates open-source blockchain infrastructure that serves pharmaceutical manufacturers (GSK, MSD, AbbVie, Takeda, Elanco, Moderna), distributors (Zuellig Pharma), healthcare providers, patients, regulatory authorities, clinical research organizations, and academic institutions. Its mission centers on pre-competitive, vendor-agnostic collaboration to address counterfeit medicines, supply chain opacity, fragmented product information, and clinical trial inefficiencies that no single organization can solve alone.
The technical core is the Product Trust Platform™, which uses blockchain as a resolver for product identification via GTIN barcodes, with a GxP-qualified, ISO 9001-aligned infrastructure compliant with 21 CFR Part 11, EU Annex 11, and 21 CFR 820. Building on this platform, PLA offers ePI by PharmaLedger™ (a mobile app delivering electronic product information across 46 countries in 29 languages, launched April 2023), AstraLabel™ (a SaaS digital labelling platform with Core, Solo, and Edge deployment models launching commercially in January 2026), AstraTrace™ (supply chain inventory visibility), and clinical trial modules including eConsent, eEnrollment, and IoT medical device integration. Digital twin technology with IoT sensor inputs and AI-based anomaly detection supports end-to-end supply chain traceability.
Revenue is generated through annual membership fees across four tiers (Patron, Standard, Public, Patient Organization), service contracts for AstraLabel deployment and technical infrastructure management, and event sponsorships. At least 5% of membership fee income is allocated to innovation activities. The association is governed by a Board elected from patron, standard, public, and patient organization members, with the Executive Director reporting to the Board. Operations are anchored in Basel, Switzerland, with a documented team of approximately 10-20 core personnel supplemented by contractors and member-organization contributors.
Pharmaledger firmographics
Firmographics- Name
- Pharmaledger
- Legal name
- PharmaLedger Association
- Website
- https://pharmaledger.org
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- PharmaLedger Association is a Swiss non-profit building a blockchain-based Digital Trust Ecosystem in Healthcare. It serves pharmaceutical manufacturers, providers, patients, and regulators with electronic product information, supply chain traceability, and a GxP-qualified open-source blockchain platform.
- Ownership category
- akta.pro rank
Pharmaledger industry classification
Industry- Product category
- Healthcare Blockchain Platforms
- NAICS
- Software Publishers (51321), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Consent, Preference & Data Rights Management (incl. HIPAA/GDPR support) (HLACAIAG)
- akta.pro secondary industries
- Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ), Medication Inventory, Procurement & Supply Chain (Pharmacy) (HLACAKAI), Access Policy, Advocacy & Stakeholder Management (HLAIAKAL)
Keywords
Where Pharmaledger is headquartered
LocationHeadquarters
- HQ city
- Manchester
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Pharmaledger business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Revenue model
- Membership Fees: The association generates revenue through membership fees from patron, standard, public, and patient organization members. Fees are confirmed annually by the General Assembly. At least 5% of membership fee income finances innovation activities.
- Service Contracts: PLA provides services including product deployment, implementation support, and technical infrastructure management for members and clients using AstraLabel and other platforms.
- Events and Sponsorships: Revenue generated from hosting and participating in events, webinars, and conferences in the healthcare and blockchain space.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Membership tiers: Patron, Standard, Public, and Patient Organization |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
Pharmaledger product offering
Product offeringCore offering
PharmaLedger Association (PLA) operates a blockchain-based Digital Trust Ecosystem in Healthcare (DTE-H) that delivers open-source platforms for digital pharmaceutical labelling (AstraLabel), electronic product information delivery (ePI), and supply chain inventory visibility (AstraTrace). The association sells SaaS deployment access and provides professional services to pharmaceutical manufacturers, healthcare providers, and clinical research organizations across 46 countries.
Product overview
PharmaLedger Association operates as a non-profit organization building a Digital Trust Ecosystem in Healthcare (DTE-H) through a portfolio of interconnected blockchain-powered products. The core platform is the Product Trust Platform™, which hosts AstraLabel™ as the primary SaaS offering (launching 2026) for digital labelling and ePI deployment. The primary end-user product is ePI by PharmaLedger™, a mobile application providing electronic product information via barcode scanning. AstraTrace™ delivers supply chain inventory visibility. Additional offerings include eConsent, eEnrollment, and IoT Medical Devices Integration for decentralized clinical trials. AstraLabel™ serves as the unified engine powering AstraTrace™ and ePI, with deployment models (Core, Solo, Edge) supporting organizations of varying scale and digital maturity.
Differentiator
Problem solved
Functional benefit
Brands
- AstraLabel: Compliant digital labelling and ePI platform for regulators and manufacturers. A SaaS platform enabling real-time, secure delivery of approved labelling content to packaging, supply chain operations, regulatory portals, and patient/HCP devices. Available in Core, Solo, and Edge deployment models.
- AstraTrace
- ePI by PharmaLedger
- Product Trust Platform
- Digital Trust Ecosystem in Healthcare (DTE-H)
Products and services
- AstraLabel™ SaaS platform for compliant digital labelling and ePI deployment that enables real-time, secure delivery of approved labelling content directly to packaging, supply chain operations, regulatory portals, and patient/HCP devices. Designed for regulatory traceability, data privacy, zero-paper operations, and interoperability.
- ePI by PharmaLedger™ Mobile application delivering real-time SmPC, ePIL, and labelling content to patients and healthcare practitioners via barcode scanning on product packaging. Accessible without download or registration; currently operational in 46 countries and 29 languages.
- AstraTrace™ Inventory visibility solution providing near real-time tracking across the pharmaceutical supply chain, enhancing patient safety, reducing medication waste, and ensuring integrity of medicines from production to patient.
- Product Trust Platform™ Underlying blockchain-based platform that powers PLA's digital solutions including ePI and supply chain traceability. Ensures tamper-evident records and transparent product information exchange across the Digital Trust Ecosystem in Healthcare.
- eConsent (Decentralized Clinical Trials) Blockchain-based informed consent platform for clinical trials providing secure, transparent, and traceable consent data management with decentralized data distribution across multiple nodes.
- eEnrollment/eRecruitment Neutral, sponsor-agnostic platform for participant matching in clinical trials using advanced search capabilities and personalized recommendations to help match patients with suitable trials.
- IoT Medical Devices Integration Enables real-time data acquisition and processing directly from participant IoT medical devices to researchers, supporting personalized medicine through continuous health monitoring, treatment adherence tracking, and adverse event identification.
- Product Trust Platform 2.0 Next-generation blockchain infrastructure for global product traceability and patient safety that will power AstraLabel and other PLA solutions from January 2026.
Quantifiable outcome
- ePI by PharmaLedger deployed across 46 countries in 29 languages
- +3 more outcomes
Companies that use Pharmaledger
Customer profileNamed customers1 record
Segments6 records
Ideal customer profiles3 records
Pharmaledger technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability3 records
Feature5 records
Pharmaledger partnerships and signals
Strategic signalPartnerships
21 partnerships are on record, tiered core and minor.
- Glemser TechnologiescorePLA partnered with Glemser Technologies, a PLA member company, to provide seamless XML conversion services at scale for AstraLabel customers. Glemser manages XML to ePI conversion activities ensuring compliance and governance while PharmaLedger provides the validated technology platform.
- PDMFCcorePDMFC, a PLA member company, was selected as the development partner for Product Trust Platform 2.0. Under PLA's leadership, PDMFC is building the next-generation infrastructure that will power AstraLabel serving PLA members and clients starting January 2026.
- GSKcoreBritish multinational pharmaceutical and biotechnology company and Patron member of PharmaLedger Association, contributing to governance and strategic direction of the Digital Trust Ecosystem.
- MSD (Merck & Co.)coreAmerican multinational pharmaceutical company and Patron member. Hosted ePI technical workshop at Prague offices in May 2023. Contributes to association governance and product development.
- AbbViecorePharmaceutical Research & Development company and member of PharmaLedger, participating in association governance and ecosystem initiatives.
- TakedacoreJapanese multinational pharmaceutical company and member contributing to Digital Trust Ecosystem initiatives and governance.
- ElancominorAnimal health pharmaceutical company and member of PharmaLedger Association participating in ecosystem activities.
- Zuellig PharmacoreHealthcare distribution, commercialisation, technology, clinical trial management, and patient care company. Member representing distributor/wholesaler perspective in ecosystem.
- Partisia BlockchaincorePrivacy and scalability blockchain technology provider. Provides blockchain infrastructure expertise for the GxP-qualified network and Product Trust Platform.
- European Patients ForumcorePatient organization representing patients' interests in healthcare. Co-designs patient-centric solutions like ePI and provides patient perspective in governance.
- CERTHminorCentre for Research & Technology Hellas - research institution contributing academic expertise to ecosystem projects.
- Consorzio DafneminorItalian consortium contributing to pharmaceutical supply chain and traceability initiatives.
- University of ThraceminorAcademic institution (Democritus University of Thrace) contributing research capabilities to ecosystem projects.
- Michigan State UniversityminorAcademic institution member contributing research and education to healthcare blockchain initiatives.
- allpack Pharma PackagingminorPharmaceutical packaging company providing expertise in smart packaging and serialization for supply chain traceability.
- INCMminorMember organization contributing to pharmaceutical information and labelling initiatives.
- activeage.orgminorOrganization focused on active aging contributing patient-centered perspective to ecosystem.
- MED ADITUSminorHealthcare access and medicine distribution company contributing to pharmaceutical access initiatives.
- ZVEZA Organizacij pacientov SlovenijaminorSlovenian patient organization representing patient interests in healthcare ecosystem.
- ModernaminorBiopharmaceutical company and member contributing to vaccine and therapeutic product trust initiatives.
- Council of Supply Chain Management Professionals (CSCM)minorIndustry association providing supply chain expertise and standards knowledge to ecosystem.
Scale indicators4 records
Recent moves10 records
Expansion highlights6 records
Pharmaledger competitors and assessment
Company assessmentDirect peers
- TraceLink: TraceLink provides pharmaceutical supply chain traceability and serialization software, including blockchain-enabled network solutions for track-and-trace and product verification. It is a direct competitor to PLA's AstraTrace and Product Trust Platform in pharma supply chain visibility.
- Optel Group: Optel provides pharmaceutical serialization, traceability, and supply chain visibility solutions including digital label and packaging intelligence, overlapping directly with AstraTrace and AstraLabel use cases.
- Partisia Blockchain: Partisia provides the underlying privacy-focused blockchain infrastructure that powers PLA's GxP-qualified network. It is both a technology partner and a peer in the enterprise blockchain-for-healthcare category.
- Antares Vision Group (Rfxcel): Antares Vision, including the Rfxcel acquisition, provides serialization, traceability, and digitalization solutions for the pharmaceutical and life sciences industries. It directly overlaps with PLA's supply chain traceability and digital labelling positioning.
- MediLedger (Chronicled): MediLedger, built on blockchain infrastructure, focuses on pharma supply chain provenance and chargeback management. It is one of the closest functional analogues to PLA's blockchain-based pharma trust ecosystem.
Broad incumbents
- Veeva Systems: Veeva provides cloud-based content management, regulatory, and quality solutions for the pharmaceutical industry, and is already integrated with AstraLabel. It is a broad incumbent that could compete with or distribute PLA's digital labelling capabilities.
- SAP Healthcare: SAP provides enterprise resource planning and supply chain software widely used across pharmaceutical manufacturers, with AstraLabel integrating into SAP. As a broad incumbent, SAP could embed equivalent digital labelling and traceability functionality natively.
- IQVIA: IQVIA is a large provider of clinical research, data, and technology services to the pharmaceutical industry. Its clinical trial and real-world data capabilities overlap with PLA's decentralized clinical trials (eConsent, eEnrollment, IoT) offerings.
Emerging players
- Movemedical: Movemedical offers cloud-based software for medical device sales, inventory, and supply chain management. It is an emerging adjacent player with comparable focus on medical product traceability, though oriented toward medtech rather than pharma.
- Truveta: Truveta aggregates de-identified clinical data from health systems and partners with life sciences companies on research and analytics. It is an emerging player in healthcare data platforms with thematic overlap to PLA's data-driven DTE-H vision.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Pharmaledger social profiles
Digital presencePharmaledger compliance and trust
Trust signalCompliance7 records
Pharmaledger financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pharmaledger leadership team
Management profileNumber of profiles
Profiles5 records
Pharmaledger funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pharmaledger M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pharmaledger
What does Pharmaledger do?
PharmaLedger Association (PLA) operates a blockchain-based Digital Trust Ecosystem in Healthcare (DTE-H) that delivers open-source platforms for digital pharmaceutical labelling (AstraLabel), electronic product information delivery (ePI), and supply chain inventory visibility (AstraTrace). The association sells SaaS deployment access and provides professional services to pharmaceutical manufacturers, healthcare providers, and clinical research organizations across 46 countries.
Is Pharmaledger a public or private company?
Pharmaledger is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Pharmaledger founded?
Pharmaledger was founded in 2022. It employs 51 to 100 people.
Where is Pharmaledger based?
Pharmaledger is headquartered in Manchester, United Kingdom, in the Europe region.
How does Pharmaledger make money?
Three revenue lines are on record. Membership Fees are the primary driver. The others are service Contracts and events and Sponsorships.
Who are Pharmaledger's main competitors?
Direct peers on record are TraceLink, Optel Group, Partisia Blockchain, Antares Vision Group (Rfxcel) and MediLedger (Chronicled). Broad incumbents are Veeva Systems, SAP Healthcare and IQVIA. Emerging players are Movemedical and Truveta.
Does Pharmaledger have an API?
No public API is recorded for Pharmaledger.
What industry is Pharmaledger in?
Pharmaledger's product category is Healthcare Blockchain Platforms. Its primary akta.pro industry code is HLACAIAG, Consent, Preference & Data Rights Management (incl. HIPAA/GDPR support), with a secondary code of BPADANAJ, Health, Pharmaceuticals & Medical Devices Regulatory Cooperation. Its NAICS code is 51321 and its SIC code is 5047.